INTRODUCTION
Microglial cells, the resident macrophages in the brain, regulate homeostasis in physiological conditions and in response to injury or inflammation by performing phagocytosis and producing chemokines (Mallat et al., 2005; Ransohoff and Brown, 2012; Ransohoff and Engelhardt, 2012; Wynn et al., 2013) . Beyond their immune functions, microglia were recently shown to modulate synaptic transmission and synaptogenesis (Bé chade et al., 2013; Li et al., 2012; Parkhurst et al., 2013; Pascual et al., 2012) and to contribute to the maturation of neural circuits (Cunningham et al., 2013; Kettenmann et al., 2013; Paolicelli et al., 2011; Schafer et al., 2012 Schafer et al., , 2013 Sierra et al., 2010; Tremblay et al., 2010; Ueno et al., 2013; Hoshiko et al., 2012) , in part by regulating neurogenesis and activity-dependent remodeling of networks in both perinatal pups and mature animals. Remarkably, impaired microglial functions in mice have been shown to induce behavioral deficits related to clinical symptoms of schizophrenia, obsessive-compulsive, and autism-spectrum disorders (Chen et al., 2010; Derecki et al., 2012 Derecki et al., , 2013 Zhan et al., 2014) .
Over the past decade, the ontogeny of neuropsychiatric disorders has been related to developmental defects in forebrain wiring that lead to modifications in dopamine circuits, the balance of excitation/inhibition in the neocortex, and impaired functional connectivity (Lewis et al., 2005; Marín, 2012; Money and Stanwood, 2013; Mulle, 2012; Poduri et al., 2013; Qiu et al., 2012; Sullivan et al., 2012; Volk and Lewis, 2013) . In addition to postnatal phases of synaptic maturation (Del Pino et al., 2013; Hoshiko et al., 2012; Zhan et al., 2014) , embryogenesis has been shown to constitute one of the critical stages for the wiring and later functioning of forebrain circuits (Fé nelon et al., 2013; Meechan et al., 2009; Steinecke et al., 2012) . In particular, prenatal inflammation resulting from either bacterial or viral infections of the mother during pregnancy constitutes a major risk factor for the occurrence of schizophrenia and autistic syndromes (Brown and Derkits, 2010; Carpentier et al., 2013; Patterson, 2009) .
Microglia derive from yolk sac primitive macrophage progenitors that invade the brain at very early embryonic stages (Ginhoux et al., 2010 (Ginhoux et al., , 2013 Kierdorf et al., 2013; Schulz et al., 2012) when other glial cells, such as astrocytes and oligodendrocytes, are not yet generated. Embryonic brain colonization by microglia is a highly conserved feature across vertebrate species (Ashwell, 1991; Herbomel et al., 2001; Perry et al., 1985; Schlegelmilch et al., 2011; Swinnen et al., 2013; Verney et al., 2010) . These immune cells, which constitute fine-tuned sensors of inflammatory signals, are thus present at all stages of brain development, including the prenatal stage of neuronal circuit formation. Such observations raised the possibility that microglia could have an embryonic role in forebrain wiring, which may contribute to the deleterious neurological outcome of microglial dysfunction.
RESULTS AND DISCUSSION
To investigate the prenatal role of microglia, we first reexamined their localization in the forebrain (Ashwell, 1991; Swinnen et al., 2013) by taking advantage of the cx3cr1 gfp/+ line (Jung et al., 2000) , where the green fluorescent protein (gfp) gene is inserted into the locus of the fractalkine receptor (Zhuang et al., 2007) . At mid-neurogenesis, GFP-positive microglia exhibited a transiently uneven distribution, which contrasted with the relatively homogeneous distribution observed at embryonic day 12.5 (E12.5) and in postnatal pups or adults ( Figures 1A-1C) . Indeed, E14.5 microglia, which showed a round or more ramified morphology ( Figure S1 ; Ekdahl et al., 2003; Sierra et al., 2010) , formed focal accumulations or ''hotspots'' and avoided specific territories ( Figure 1B ). Using coimmunolabeling, we found that microglia were not located inside blood vessels and were not associated with local cell death ( Figure S1 ; Ashwell, 1991) or with progenitor zones, as observed later around or after birth (Cunningham et al., 2013; Sierra et al., 2010) . In contrast, microglia accumulated at decision points along specific axonal tracts. For instance, microglia transiently associated with the extremities of tyrosine-hydroxylase (TH)-positive midbrain dopaminergic axons as they entered the subpallium, as opposed to adjacent serotoninergic or internal capsule fibers, such as thalamocortical and corticothalamic (Figures 1D and S1 ; data not shown). Furthermore, in the neocortex, GFP-positive microglia were largely excluded from the cortical plate until E16.5, which they progressively invaded in a timely manner, starting with the deeper layers (Figures 1E and 1F ; Arnoux et al., 2013; Swinnen et al., 2013) . The association of microglia with dopaminergic axons and their timely invasion of the cortical plate suggested that they might participate in the development of these two structures, both of which have been linked to neuropsychiatric disorders.
To address this issue, we designed a cross-comparative analysis of prenatal phenotypes induced by either an absence of microglia or their immune activation. We first generated a mouse model of embryonic depletion by transiently blocking the CSF-1R signaling pathway required for the maintenance and differentiation of yolk sac macrophages, the microglial precursors ( Figures 1G-1L ). This depletion was achieved by injections of anti-CSF-1R antibody at E6.5 and E7.5, when yolk-sac macrophages are being generated (Ginhoux et al., 2010 (Ginhoux et al., , 2013 Orkin and Zon, 2008; Wang et al., 2012) . Flow cytometry and immunohistochemistry indicated that this procedure specifically affected yolk-sac macrophages ( Figure S1 ), thereby leading to a dramatic depletion of microglia throughout embryogenesis ( Figures  1I-1L) . However, the depletion was transient, as the microglial LGE, lateral ganglionic eminence; MGE, medial ganglionic eminence; Ncx, neocortex; Str, striatum. Scale bars represent 500 mm in all panels except for (E) and (F), where they represent 200 mm. See also Figure S1 . population progressively reached its normal level during the first postnatal weeks ( Figures 1G and 1H ). Since CSF-1R blockade could have effects unrelated to microglial depletion (Nandi et al., 2012) , we compared depleted embryos with Pu.1 À/À embryos, in which the inactivation of the transcription factor PU.1 disrupts the generation of all myeloid cells, including microglia (Back et al., 2004; Erblich et al., 2011) . Together with the two mouse models lacking microglia, we examined cx3cr1 gfp/+ embryos that had been exposed to maternal immune activation (MIA) at E13.5 via intraperitoneal injections of lipopolysaccharide (LPS), a component of the envelope of Gram-negative bacteria (Patterson, 2009 ). This procedure, which induces long-lasting behavioral defects in the offspring (Carpentier et al., 2013; Hava et al., 2006; Kirsten et al., 2010; Patterson, 2009; Prinz et al., 2011) , triggers an immune activation of embryonic microglia detailed analysis using coimmunolabeling revealed that normal microglial activity was not required for the overall patterning of the forebrain, early neurogenesis, or the formation of blood vessels (n = 3 for each model; Figure S2 ). At mid-neurogenesis, we found no defects in internal capsule and serotoninergic fibers (data not shown), and focused on adjacent dopaminergic axons. Indeed, 3D reconstruction of confocal images and electron microscopy respectively revealed that microglia and TH-positive axons were in direct contact at the entrance of the subpallium and that TH-positive axon fragments were detected inside the cytoplasm of GFP-positive microglia (Figures 2A-2D ). These figures of engulfment suggest that in physiological conditions, microglia might phagocyte fragments of dopaminergic axons. Strikingly, dopaminergic axons exhibited remarkably consistent modifications in their embryonic outgrowth in all three models ( Figures 2E-2H' ). In E14.5 control embryos, dopaminergic axons, identified by their anti-TH immunoreactivity, stalled at the entry of the subpallium before extending into and innervating the basal ganglia and neocortex (Prestoz et al., 2012; Van den Heuvel and Pasterkamp, 2008; Figures 2E, 2E', and S1) . In both cx3cr1 gfp/+ -depleted and Pu.1 mutant embryos (n depleted = 4; n Pu.1À/À = 6), we observed an exuberant extension of TH-positive axons into the subpallium , whereas the population of dopaminergic neurons in the midbrain was not modified (data not shown). By contrast, MIA (n LPSinj = 9) induced a mild but robust reduction in the extension of TH-positive axons into the subpallium of the embryonic brains ( Figures 2E, 2E ', 2H, 2H', and 2L). Remarkably, these early embryonic modifications in dopaminergic axon extension were associated with a coherent imbalance in the dopaminergic innervation of the striatum at birth (Figures 2I-2K ). Although Pu.1 À/À mutants could not be examined since they die at birth, we observed a dorsal extension of TH labeling in the striatum of depleted neonates and, conversely, a ventral increase in MIA neonates ( Figures 2I-2K ). Thus, normal activity of microglia limits the embryonic outgrowth of dopaminergic axons in the forebrain. Since microglial distribution is particularly dynamic in the developing neocortex (Figures 1E and 1F ; Swinnen et al., 2013) , we examined the process of corticogenesis in the three mouse models. We first examined cortical lamination at E18.5 using deep-layer and upper-layer molecular markers (Tbr1, Ctip2, and Cux1) and found no difference between the models of microglial depletion, absence, or immune activation (n = 3-6 for each model; Figure S2 ). The timely pattern of microglia invasion through the developing cortical plate, which contains maturating cortical neurons, recapitulated the pattern of two other major events of neocortical development: (1) the entrance of incoming axonal inputs from the thalamus (Molná r et al., 2012) and (2) the cortical plate laminar positioning of inhibitory interneurons, which originate in the subpallium and are essential for the functioning of neocortical neural circuits (Hevner et al., 2004; Lavdas et al., 1999; Ló pez-Bendito et al., 2006) . By performing L1 and neurofilament (2H3) immunolabeling of E18.5 cortical and thalamic axons or only thalamic axons, respectively, we found that microglial activity was not required for correct timing of thalamic axon invasion of the cortical plate (n = 3 for each model; Figure S2 ). In sharp contrast, the absence or immune activation of microglia had a marked impact on the positioning of specific subsets of cortical interneurons (Figure 3 ). Neocortical inhibitory interneurons regulate the balance of excitation/inhibition via distinct laminar localization and physiological properties (Gelman et al., 2012; Gelman and Marín, 2010) . They originate in the subpallium, migrate tangentially into the neocortex (predominantly outside of the cortical plate), and then migrate radially into the cortical plate to reach their laminar position (Gelman and Marín, 2010; Lavdas et al., 1999; Tanaka and Nakajima, 2012) . Distinct subpopulations of interneurons originate in specific subpallial territories and exhibit unique molecular and cellular properties. In particular, subsets of interneurons express the transcription factor Lhx6 and give rise to somatostatin-positive interneurons as well as a collection of fast-spiking interneurons that play critical roles in cortical microcircuits (Liodis et al., 2007) . Using in situ hybridization on E16.5 (n depleted = 3; n Pu.1À/À = 4; n LPSinj = 3) and E18.5 (n depleted = 5; n Pu.1À/À = 7; n LPSinj = 6) embryos that lacked microglia or were exposed to MIA, we found that Lhx6-expressing interneurons entered prematurely into the cortical plate and had a less focal distribution around layer V than in control animals ( Figures 3A-3I ). This abnormal distribution in the cortical plate, which we similarly observed by immunostaining (data not shown), was specific for Lhx6-expressing interneurons, as the position of Reelin-expressing interneurons was not perturbed in our mouse models (E18.5, n depleted = 4; n Pu.1À/À = 3; n LPSinj = 6; P7, n depleted = 5; n LPSinj = 4; Figure S3 ). Since cortical interneurons continue migrating up to the end of the first postnatal week (Hevner et al., 2004; Inamura et al., 2012) , we tested whether this abnormal distribution of Lhx6-expressing interneurons was preserved at the end of migration. For this purpose, we examined P7-depleted and MIA pups, and observed an imbalance in the distribution of Lhx6-positive interneurons in neocortical upper layers in both models (n depleted = 6; n LPSinj = 7; Figures 3J-3N ). Among Lhx6-expressing interneurons, the abnormal distribution most likely affected fast-spiking neurons, since somatostatin-expressing interneurons were normally confined to deep cortical layers in both experimental models (n depleted = 4; n LPSinj = 4; Figure S3 ). We LGE, lateral ganglionic eminence; MGE, medial ganglionic eminence; n, nucleus; Ncx, neocortex; Str, striatum. Scale bars equal 50 mm (A), 20 mm (B), 5 mm (C), 500 mm (E and E'), and 250 mm (I). See also Figure S2 . thus examined fast-spiking interneurons, which are easily visualized later by parvalbumin (PV) immunoreactivity at P20 ( Figures  3O-3S ). Their distribution was mildly but reproducibly affected, leading to an approximately 10% increase in the number of PVpositive interneurons in layers III/IV (n depleted = 4; n LPSinj = 3; Figures 3O-3S ). These findings reveal that abnormal microglial activity, due either to their prenatal absence or activation, perturbs the precise localization of Lhx6-expressing neocortical interneurons both embryonically and postnatally. Since defective interneuron migration and distribution have been also observed in mouse models of neurodevelopmental disorders (Meechan et al., 2009 (Meechan et al., , 2012 , microglia dysfunction and genetic predisposition factors may converge onto common targets.
To further characterize the embryonic role of microglia, we examined mutant mouse lines that affect microglial functions. Cx3cr1 À/À mice have impaired microglia/neuron communication that leads to defective synapse pruning and maturation, and also exhibit behavioral deficits related to neurodevelopmental disorders (Hoshiko et al., 2012; Paolicelli et al., 2011; Zhan et al., 2014) . Complement receptor 3 (CR3) mutant mice have been shown to affect microglial activity in the activity-dependent postnatal synaptic pruning of retinocollicular axons (Schafer et al., 2012) . Finally, inactivation of the adaptor protein DAP12 has been shown to perturb the functioning of macrophages, including microglia, and its mutation in humans is associated with a complex syndrome that includes presenile dementia (Paloneva et al., 2001; Roumier et al., 2004; Thrash et al., 2009; Wakselman et al., 2008) . Consistent with our analyses of depleted and MIA mice, we found that none of the three mutations induced an overall change in forebrain patterning, early neurogenesis, blood vessel formation, or cortical lamination (n = 3 for each model; Figure S4 and data not shown). Since CR3 had been involved in pruning, we specifically examined whether this receptor contributes to the microglial activity on the extension of TH-positive axons (Figure 4) . We found that neither the inactivation of CR3 nor that of DAP12 affected the outgrowth of dopaminergic axons in the subpallium (n CR3À/À = 6; n Dap12À/À = 9; Figures 4A, 4A', 4C, 4C', and 4F; data not shown). By contrast, we observed a reproducible defect in cx3cr1 À/À mutant embryos (n cx3cr1À/À = 7; Figures 4A-4B' and 4F), which correlated with a mild expansion of TH innervation at birth (n cx3cr1À/À = 5; Figures  4D and 4E ). We next analyzed the distribution of Lhx6-expressing interneurons and found that inactivation of both DAP12 and cx3cr1 led to an imprecision in their distribution at E18.5 (n Dap12À/À = 6; n cx3cr1À/À = 7) and P7 pups (n Dap12À/À = 5; n cx3cr1À/À = 7; Figures 4G-4P ). These consistent phenotypes were specific for Lhx6-expressing interneurons, since neither Reelin-expressing nor Somatostatin-expressing interneurons were affected (data not shown). Interestingly, neocortical positioning of microglia in cx3cr1 À/À mutants showed a mild change ( Figure S4 ), suggesting that microglial misplacement could contribute to the observed phenotype, as has been proposed for postnatal synaptogenesis (Paolicelli et al., 2011) . Taken together, these results show that the defects observed in both TH-positive axons and interneurons partially recapitulated those found in depleted and MIA mice. Thus, the results indicate that CX3CR1 signaling and the adaptor protein DAP12 are involved in several or specific embryonic activities of microglia, respectively. Overall, our study demonstrates that embryonic microglia, via their specific localization, act as modulators of two major events associated with the pathological wiring of the forebrain: dopaminergic axon outgrowth and neocortical interneuron positioning. Thus, in addition to their reported perinatal and postnatal roles, microglia contribute to the embryonic wiring of the forebrain. This fine-tuning activity, which involves CX3CR1 and DAP12 signaling, impacts the postnatal development of neocortical microcircuits. These findings unveil an integrated interplay between the prenatal development of the nervous and immune systems and provide a framework for understanding the etiology of neuropsychiatric diseases.
EXPERIMENTAL PROCEDURES

Mouse Lines
Cx3cr1
+/gfp (Jung et al., 2000) , Pu.1 +/À (Back et al., 2004) , Spriel et al., 2001) , and Dap12 À/À (Tomasello et al., 2000) mice were maintained on a C57/Bl6 background. C57/Bl6 mice or heterozygotes were used as controls, as they did not exhibit any phenotype. The day of vaginal plug was considered E0.5. Animals were handled in accordance with European regulations and the local ethics committee.
Microglial Depletion and LPS Prenatal Injections
Pregnant C57/Bl6 females were administered anti-CSF-1R mAb (aCSF-1R, clone AFS98) or the rat IgG2a isotype control (clone R35-95; BD Biosciences) intraperitoneally at E6.5 and E7.5 (3 mg per day in sterile PBS). aCSF-1R mAb was purified from the culture supernatant of the AFS98 hybridoma (Sudo et al., 1995) , which was grown in a CELLine Flask (BD) in serum-free medium (PFHM-II; Invitrogen). The efficiency of the procedure was assessed by fluorescenceactivated cell sorting (FACS) analyses as described previously (Ginhoux et al., 2010) . Pregnant C57/Bl6 females were administered LPS in sterile PBS (0.12 mg/g mouse; InvivoGen) at E13.5 by a single intraperitoneal injection. Control C57/Bl6 pregnant females were injected at E13.5 with sterile PBS and showed no detectable phenotype.
allowing the visualization of cortical layers. In controls, Lhx6-positive interneurons (arrowheads in E) are concentrated in layer V (dotted lines in E'-H'). They are more uniformly distributed across the neocortical layers of brains from depleted and Pu.1 À/À mice and are less concentrated in layer V of brains from MIA animals (arrowheads in F-H).
(I) Quantification of Lhx6 signal across E18.5 somatosensory neocortical layers (divided into ten bins) in brains from control versus depleted, Pu.1
, and MIA mice, respectively. (J-N) Lhx6 in situ hybridization on P7 somatosensory cortex coronal sections shows a relatively increased signal in layers II-IV in brains from depleted mice (J and K) and a relatively increased signal in layers II-III and decreased signal in layer IV in brains from MIA mice (J and M). (L and N) Both phenotypes were quantified as in (I).
(O-S) PV immunostaining on P20 coronal sections through the somatosensory cortex (divided into five bins) shows a relative increase in the upper layers of depleted and MIA mice (blue box delineates bin 2). Quantification shows a mild but significant defect in the distribution. *p < 0.05, **p < 0.01, ***p < 0.001; MannWhitney test. Data are presented as mean ± SEM. CP, cortical plate; IZ, intermediate zone; Ncx, neocortex; UL, upper layers. Scale bars equal 500 mm (A and E), 250 mm (E' and J), and 100 mm (O). See also Figure S3 .
In Situ Hybridization, Immunohistochemistry, Electron Microscopy, Image Acquisition, and Quantification For further details regarding the materials and methods used in this work, see Supplemental Experimental Procedures.
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